Cargando…
Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381625/ https://www.ncbi.nlm.nih.gov/pubmed/32709851 http://dx.doi.org/10.1038/s41408-020-00342-x |
| _version_ | 1783563082800300032 |
|---|---|
| author | Locatelli, Franco Zugmaier, Gerhard Mergen, Noemi Bader, Peter Jeha, Sima Schlegel, Paul-Gerhardt Bourquin, Jean-Pierre Handgretinger, Rupert Brethon, Benoit Rossig, Claudia Chen-Santel, Christiane |
| author_facet | Locatelli, Franco Zugmaier, Gerhard Mergen, Noemi Bader, Peter Jeha, Sima Schlegel, Paul-Gerhardt Bourquin, Jean-Pierre Handgretinger, Rupert Brethon, Benoit Rossig, Claudia Chen-Santel, Christiane |
| author_sort | Locatelli, Franco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7381625 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73816252020-07-28 Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study Locatelli, Franco Zugmaier, Gerhard Mergen, Noemi Bader, Peter Jeha, Sima Schlegel, Paul-Gerhardt Bourquin, Jean-Pierre Handgretinger, Rupert Brethon, Benoit Rossig, Claudia Chen-Santel, Christiane Blood Cancer J Correspondence Nature Publishing Group UK 2020-07-24 /pmc/articles/PMC7381625/ /pubmed/32709851 http://dx.doi.org/10.1038/s41408-020-00342-x Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Locatelli, Franco Zugmaier, Gerhard Mergen, Noemi Bader, Peter Jeha, Sima Schlegel, Paul-Gerhardt Bourquin, Jean-Pierre Handgretinger, Rupert Brethon, Benoit Rossig, Claudia Chen-Santel, Christiane Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study |
| title | Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study |
| title_full | Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study |
| title_fullStr | Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study |
| title_full_unstemmed | Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study |
| title_short | Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study |
| title_sort | blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the rialto trial, an expanded access study |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381625/ https://www.ncbi.nlm.nih.gov/pubmed/32709851 http://dx.doi.org/10.1038/s41408-020-00342-x |
| work_keys_str_mv | AT locatellifranco blinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT zugmaiergerhard blinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT mergennoemi blinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT baderpeter blinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT jehasima blinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT schlegelpaulgerhardt blinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT bourquinjeanpierre blinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT handgretingerrupert blinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT brethonbenoit blinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT rossigclaudia blinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT chensantelchristiane blinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy |